We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
S&P Global
SPGI
$120B
| $100M | 0.11% |
197,523
-1,382
| -0.7% | -$706K |
|
|
TLN
202
Talen Energy Corp
TLN
$17.1B
| $99.8M | 0.11% |
499,717
-6,219
| -1% | -$1.35M |
|
203
Monolithic Power Systems
MPWR
$68.9B
| $98.7M | 0.11% |
170,110
+87,206
| +105% | +$55M |
|
204
Commault Systems
CVLT
$5.78B
| $97.7M | 0.11% |
618,643
+612,552
| +10,057% | +$101M |
|
205
Gen Digital
GEN
$17.3B
| $97.6M | 0.11% |
3,678,547
-2,267,754
| -38% | -$62.1M |
|
206
Palantir
PLTR
$420B
| $97.6M | 0.11% |
1,155,679
+277,161
| +32% | +$24.3M |
|
207
Texas Instruments
TXN
$257B
| $97.3M | 0.11% |
541,663
-21,916
| -4% | -$4.1M |
|
208
Carlisle Companies
CSL
$15.5B
| $96.4M | 0.11% |
283,128
+258,913
| +1,069% | +$92.8M |
|
209
Aaon
AAON
$7.03B
| $95.1M | 0.11% |
1,216,674
+1,206,637
| +12,022% | +$124M |
|
210
TG Therapeutics
TGTX
$7.64B
| $94.5M | 0.11% |
2,397,184
-396,747
| -14% | -$13.3M |
|
211
CME Group
CME
$93.3B
| $94.2M | 0.1% |
355,014
-70,320
| -17% | -$17.3M |
|
212
Medtronic
MDT
$116B
| $93.2M | 0.1% |
1,037,677
+92,617
| +10% | +$8.29M |
|
213
Union Pacific
UNP
$174B
| $93M | 0.1% |
393,496
-202,999
| -34% | -$48.9M |
|
214
Morgan Stanley
MS
$338B
| $92.9M | 0.1% |
796,375
-57,778
| -7% | -$7.44M |
|
215
Goldman Sachs
GS
$301B
| $92.6M | 0.1% |
169,500
-44,247
| -21% | -$26.6M |
|
216
Illinois Tool Works
ITW
$83.5B
| $92.2M | 0.1% |
371,690
+22,960
| +7% | +$5.9M |
|
|
CFLT
217
DELISTED
Confluent
CFLT
| $91M | 0.1% |
3,881,590
+1,530,074
| +65% | +$44.3M |
|
218
AT&T
T
$168B
| $90.3M | 0.1% |
3,194,349
+74,350
| +2% | +$1.87M |
|
219
Comcast
CMCSA
$91.1B
| $89.8M | 0.1% |
2,432,820
+65,385
| +3% | +$2.36M |
|
220
nVent Electric
NVT
$27.1B
| $86.2M | 0.1% |
1,644,502
+933,159
| +131% | +$59M |
|
221
American States Water
AWR
$3.47B
| $86M | 0.1% |
1,093,603
-24,963
| -2% | -$1.88M |
|
222
Equifax
EFX
$21.4B
| $85.3M | 0.09% |
350,435
-327,939
| -48% | -$82.4M |
|
223
Bristol-Myers Squibb
BMY
$130B
| $85.1M | 0.09% |
1,396,090
+100,200
| +8% | +$5.84M |
|
224
Check Point Software Technologies
CHKP
$13.2B
| $84.7M | 0.09% |
371,509
+26,336
| +8% | +$5.58M |
|
|
BPMC
225
DELISTED
Blueprint Medicines
BPMC
| $84.5M | 0.09% |
954,596
-229,086
| -19% | -$22.3M |
|
Similar funds
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.